Stonnington Group’s AstraZeneca AZN Stock Holding History

Stonnington Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$697K	Buy	4,662 +250	+6%	+$33.6K	0.18%	120
2022 Q4	$632K	Sell	4,412 -250	-5%	-$31.4K	0.17%	115
2022 Q3	$508K	Sell	4,662 -3,400	-42%	-$431K	0.14%	128
2022 Q2	$1.08M	Buy	8,062 +1,100	+16%	+$144K	0.29%	74
2022 Q1	$983K	Buy	6,962 +2,000	+40%	+$240K	0.24%	94
2021 Q4	$577K	Buy	4,962 +25	+0.5%	+$2.94K	0.12%	153
2021 Q3	$598K	Buy	4,937 +1,887	+62%	+$220K	0.13%	151
2021 Q2	$361K	Hold	3,050	–	–	0.08%	208
2021 Q1	$332K	Buy	+3,050	New	+$307K	0.08%	201

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Stonnington Group's AZN Position: Q1 2023 in Review

Stonnington Group increased its AstraZeneca (AZN) stake by 5.7% in Q1 2023, buying an estimated $33.6K and bringing the position to 4,662 shares worth $697K. The position accounts for 0.18% of the portfolio, ranked #120.

Stonnington Group first reported a position in AZN in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.08M in Q2 2022. 1,055 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

Stonnington Group held 4,662 shares of AstraZeneca worth $697K as of Q1 2023.
Stonnington Group bought 250 AstraZeneca shares in Q1 2023, an estimated $33.6K.
AstraZeneca made up 0.18% of Stonnington Group's portfolio in Q1 2023, its #120 holding.
Stonnington Group first reported a position in AstraZeneca in Q1 2021 and has held it in 9 quarters since.
Stonnington Group's AstraZeneca position peaked at $1.08M in Q2 2022.
1,055 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.